271. Ankylosing spondylitis Clinical trials / Disease details

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00085644 (ClinicalTrials.gov)	January 2004	10/6/2004	Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis	A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis	Ankylosing Spondylitis	Biological: adalimumab (D2E7);Biological: placebo	Abbott	NULL	Completed	18 Years	N/A	All	315	Phase 3	United States
2	NCT00195819 (ClinicalTrials.gov)	December 2003	16/9/2005	Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis	A Phase 3, Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis	Ankylosing Spondylitis	Biological: adalimumab (D2E7);Biological: placebo	Abbott	NULL	Completed	18 Years	N/A	All	82	Phase 3	Canada;United States